Literature DB >> 3083776

Phospholipid metabolism in human neutrophil subfractions.

D M Smith, M Waite.   

Abstract

We describe a procedure for isolating human neutrophil subfractions by sucrose density centrifugation following nitrogen cavitation. Using this procedure we were able to isolate and characterize a cytosolic fraction, two separate plasma membrane-enriched fractions, and specific and azurophilic granule fractions. We used this procedure to examine the subcellular localization of the enzymes and substrates involved in the release of arachidonic acid from cellular phospholipids in response to whole cell stimulation. Whole cells were prelabeled for 2 h with [3H]arachidonic acid and [14C] stearic acid. When prelabeled cells were challenged with calcium ionophore A23187 (2 microM) for 5 min at 37 degrees C, each membrane-associated fraction, including both plasma membrane fractions and specific and azurophilic granule fractions, exhibited deacylation of phosphatidylinositol (PI) and phosphatidylcholine (PC). The specific granule fraction exhibited the greatest proportion of deacylation from PI while the more dense plasma membrane fraction was deacylated to a much lower extent than the other fractions. In terms of mass, the azurophilic granules deacylated the greatest amount of radiolabeled arachidonic acid. Although all membrane fractions may be sources of arachidonic acid to some extent, the azurophilic granule fraction may contain the largest pool of radiolabeled arachidonic acid that is released upon cell stimulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083776     DOI: 10.1016/0003-9861(86)90472-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Biochemical characterization of soluble phospholipase A2 from rheumatoid synovial fluid.

Authors:  H Gonzalez-Buritica; D M Smith; R A Turner
Journal:  Agents Actions       Date:  1989-06

2.  Evaluation of Tenidap (CP-66,248) on human neutrophil arachidonic acid metabolism, chemotactic potential and clinical efficacy in the treatment of rheumatoid arthritis.

Authors:  D M Smith; J A Johnson; R Loeser; R A Turner
Journal:  Agents Actions       Date:  1990-08

3.  Phorbol 12-myristate 13-acetate inhibits binding of leukotriene B4 and platelet-activating factor and the responses they induce in neutrophils: site of action.

Authors:  M Yamazaki; J Gomez-Cambronero; M Durstin; T F Molski; E L Becker; R I Sha'afi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Characterisation of soluble and cell associated phospholipase A2 from rheumatoid synovial fluid.

Authors:  H Gonzalez-Buritica; D M Smith; R A Turner
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

5.  Arachidonic acid release in rabbit neutrophils.

Authors:  W Tao; T F Molski; R I Sha'afi
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

6.  Demonstration of calcium-dependent phospholipase A2 activity in membrane preparation of rabbit neutrophils. Absence of activation by fMet-Leu-Phe, phorbol 12-myristate 13-acetate and A-kinase.

Authors:  T Matsumoto; W Tao; R I Sha'afi
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

7.  Accumulation of docosahexaenoic acid in phosphatidylserine is selectively inhibited by chronic ethanol exposure in C-6 glioma cells.

Authors:  H Y Kim; J Hamilton
Journal:  Lipids       Date:  2000-02       Impact factor: 1.646

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.